Garry Nolan Ph.D., Director at Akoya Biosciences, Inc. (AKYA), sold 16,610 shares at $13.26 ($220K) on 2022-09-14, disclosed to the SEC on 2022-09-16.
Open-market sale of $220k AKYA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.26 | 8,305 | $110K | 50.0% |
| 2 | $13.26 | 8,305 | $110K | 50.0% |
| Total | $13.26 avg | 16,610 | $220K | 100% |
| Filing → |
| AKYA | SELL | 2022-12-06 | $15K | — | Filing → |
| AKYA | SELL | 2022-12-02 | $67K | — | Filing → |
| AKYA | SELL | 2022-11-17 | $4K | — | Filing → |